 "Strides receives USFDA nod to manufacture constipation drug at its Bangalore plant")
New Delhi: Strides Shasun Thursday said it has received an approval from the US health regulator for Polyethylene Elycol 3350 used for treating constipation.
In a BSE filing, Strides Shasun said: “It has received approval from the US Food and Drug Administration (USFDA) for Polyethylene Glycol 3350, powder for solution 17 grams/capful and 17 grams/packet (OTC)”.
Advertisement
The company said it will manufacture the product at its Bangalore plant and launch the product in the fourth quarter of this fiscal.
Quoting IMS sales data, Strides Shasun said the US market for Polyethylene Glycol 3350, powder for solution is around $260 million.
Strides Shasun’s shares were trading 0.88 percent higher at Rs 973.50 apiece on BSE.
 "Reliance Industries Ltd becomes India's first to surpass Rs 20 lakh crore in market capitalisation")
 "Vantage | Why investors are dumping China and moving to India")
 "India versus China: How two key emerging markets performed in 2023")
 "NSE celebrates as Nifty touches 20,000-mark for first time ever")
 "Reliance Industries Ltd becomes India's first to surpass Rs 20 lakh crore in market capitalisation")
 "Vantage | Why investors are dumping China and moving to India")
 "India versus China: How two key emerging markets performed in 2023")
 "NSE celebrates as Nifty touches 20,000-mark for first time ever")